No Data
No Data
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
Express News | Tonix Pharmaceuticals: Tolerability of Tnx‐801 Vaccination in Immune-Compromised Animal Models Supports Clinical Development
Express News | Tonix Pharmaceuticals Announces Grant by Medical Cbrn Defense Consortium (Mcdc) for Development of Tnx-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company's Single-Dose Mpox and Smallpox Vaccine Candidate